retatrutide phase 2 nejm 2023 weight loss percent 48 weeks This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Trial https://t.co/jNL1GNnHPT #Endocrinology 2023年度回顧】 NEJM Notable Articles of
Description
Designed to help regulate blood sugar levels, Ozempic has also gained attention for its ability to aid in weight loss, which has led to a surge in off-label use
Overall prescribing trends The study found that 1,162,662 patients were prescribed a GLP-1 RA between January 2018 and June 2024, with 4,815,135 total prescriptions during this period
And while hair extensions are a great temporary fix for GLP-1 medications causing hair loss in women, they can give your natural hair a much-needed break while it recovers
Q., Xu, X
Never start weight loss injections without medical supervision , particularly if you have a chronic gastrointestinal condition
